Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer

Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer

US Patent 8859562 · Granted Oct 14, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy2025
Substituted benzodiazoles and use thereof in therapy2025
Substituted benzodiazoles and use thereof in therapy2024
2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy2022
Method for treating cancer using a combination of Chk1 and ATR inhibitors2021
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions2020
MTH1 inhibitors for treatment of cancer2019
Pyrimidine-2,4-diamine derivatives for treatment of cancer2019
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions2018
Bisarylsulfonamides useful in the treatment of inflammation and cancer2018
Pyrimidine-2,4-diamine derivatives for treatment of cancer2018
Pyrimidine-2,4-diamine derivatives for treatment of cancer2017